As the activation of the TIM3 pathway or immune checkpoint pathways will lead to a “don’t eat me” effect between CD8+ T cells and MDS blasts, therapeutic strategies targeting these signaling pathways have emerged to block the immunosuppressive crosstalk. Here, HAVCR2 is linked to myelodysplastic syndrome.